Show simple item record

dc.contributor.authorAssemblée mondiale de la Santé, 16
dc.date.accessioned2015-09-17T13:45:05Z
dc.date.available2015-09-17T13:45:05Z
dc.date.issued1963
dc.identifier.govdocA16/P&B/4
dc.identifier.urihttp://www.who.int/iris/handle/10665/184687
dc.descriptionPoint 2.8 de l'ordre du jour provisoireen_US
dc.language.isofren_US
dc.publisherOrganisation mondiale de la Santéen_US
dc.subjectPharmaceutical productsen_US
dc.subject.meshPharmaceutical Preparationsen_US
dc.subject.meshDrug Evaluationen_US
dc.subject.meshSubstance-Related Disordersen_US
dc.titleÉvaluation clinique et pharmacologique des préparations pharmaceutiques: rapport du Directeur généralen_US
dc.typeGoverning body documentsen_US


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(‎s)‎

Show simple item record